Insmed Inc [INSM] stock prices are up 10.67% to $73.72 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INSM shares have gain 5.10% over the last week, with a monthly amount glided 1.99%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on April 23, 2024, when Truist initiated its Buy rating and assigned the stock a price target of $48. Previously, Wolfe Research started tracking the stock with Outperform rating on February 15, 2024, and set its price target to $42. On December 08, 2023, Wells Fargo initiated with a Overweight rating and assigned a price target of $55 on the stock. Guggenheim initiated its recommendation with a Buy and recommended $50 as its price target on July 26, 2023. Mizuho started tracking with a Buy rating for this stock on December 09, 2022, and assigned it a price target of $28. In a note dated December 07, 2022, Barclays initiated an Overweight rating and provided a target price of $37 on this stock.
The stock price of Insmed Inc [INSM] has been fluctuating between $21.92 and $80.53 over the past year. Currently, Wall Street analysts expect the stock to reach $76.25 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $73.72 at the most recent close of the market. An investor can expect a potential return of 3.43% based on the average INSM price forecast.
Analyzing the INSM fundamentals
The Insmed Inc [NASDAQ:INSM] reported sales of 342.96M for trailing twelve months, representing a surge of 18.15%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -2.14%, Pretax Profit Margin comes in at -2.51%, and Net Profit Margin reading is -2.52%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is 12.59 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 69.82 points at the first support level, and at 65.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 75.70, and for the 2nd resistance point, it is at 77.68.
Ratios To Look Out For
It’s worth pointing out that Insmed Inc [NASDAQ:INSM]’s Current Ratio is 6.37. As well, the Quick Ratio is 5.99, while the Cash Ratio is 1.78. Considering the valuation of this stock, the price to sales ratio is 38.46, the price to book ratio is 27.27.
Transactions by insiders
Recent insider trading involved Smith Michael Alexander, Chief Legal Officer, that happened on Sep 13 ’24 when 27871.0 shares were sold. Chief Medical Officer, Flammer Martina M.D. completed a deal on Sep 13 ’24 to sell 26969.0 shares. Meanwhile, Chief Medical Officer Flammer Martina M.D. sold 13436.0 shares on Sep 16 ’24.
